Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

被引：0

作者：

C Preisinger

J P Schwarz

O B Bleijerveld

E Corradini

P J Müller

K I Anderson

W Kolch

A Scholten

A J R Heck

机构：

[1] Biomolecular Mass Spectrometry and Proteomics Group,Department of Biochemistry

[2] Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences,undefined

[3] Utrecht University,undefined

[4] Netherlands Proteomics Centre,undefined

[5] The Beatson Institute for Cancer Research,undefined

[6] Garscube Estate,undefined

[7] RWTH Aachen University,undefined

[8] Systems Biology Ireland,undefined

[9] University College Dublin,undefined

[10] Belfield,undefined

[11] Centre for Biomedical Genetics,undefined

[12] 7Current address: Proteomics Facility,undefined

[13] Interdisciplinary Centre for Clinical Research (IZKF) Aachen,undefined

[14] RWTH Aachen University,undefined

[15] Aachen,undefined

[16] Germany.,undefined

来源：

Leukemia | 2013年 / 27卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：743 / 746

页数：3

共 50 条

[21] Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia
Ito, K
Tominaga, K
Suzuki, T
Jinnai, I
Bessho, M
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (03) : 242 - 245
[22] ABL-BCR expression in BCR-ABL-positive human leukemia cell lines
Uphoff, CC
Habig, S
Fombonne, S
Matsuo, Y
Drexler, HG
LEUKEMIA RESEARCH, 1999, 23 (11) : 1055 - 1060
[23] BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib
Heiblig Maël
Bidet Audrey
Callet-Bauchu Evelyne
Dumas Pierre-Yves
Chabane Kaddour
Salles Gilles
Pigneux Arnaud
Annals of Hematology, 2017, 96 : 335 - 336
[24] BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib
Mael, Heiblig
Audrey, Bidet
Evelyne, Callet-Bauchu
Pierre-Yves, Dumas
Kaddour, Chabane
Gilles, Salles
Arnaud, Pigneux
ANNALS OF HEMATOLOGY, 2017, 96 (02) : 335 - 336
[25] Imatinib restores expression of CD62L in BCR-ABL-positive cells
Fruehauf, S
Topaly, J
Schad, M
Paschka, P
Gschaidmeier, H
Zeller, WJ
Hochhaus, A
Ho, AD
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (05) : 600 - 603
[26] Imatinib Sensitivity in BCR-ABL1-Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele
Virgili, Anna
Koptyra, Mateusz
Dasgupta, Yashodhara
Glodkowska-Mrowka, Eliza
Stoklosa, Tomasz
Nacheva, Elisabeth P.
Skorski, Tomasz
CANCER RESEARCH, 2011, 71 (16) : 5381 - 5386
[27] THE BCR/ABL TYROSINE KINASE INHIBITOR IMATINIB PRODUCES PROFOUND MAST CELL DEFICIENCY IN CHRONIC MYELOID LEUKEMIA
Cerny-Reiterer, S.
Herndlhofer, S.
Stefanzl, G.
Blatt, K.
Hoermann, G.
Muellauer, L.
Beham-Schmid, C.
Baumgartner, S.
Sperr, W.
Mannhalter, C.
Linkesch, W.
Valent, P.
HAEMATOLOGICA, 2013, 98 : 293 - 293
[28] Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy
Takahashi, N
Miura, I
Kobayashi, Y
Kume, M
Yoshioka, T
Otane, W
Ohtsubo, K
Takahashi, K
Kitabayashi, A
Kawabata, Y
Hirokawa, M
Nishijima, H
Ichinohasama, R
DeCoteau, J
Miura, AB
Sawada, K
Sawada, K
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (03) : 235 - 241
[29] Molecular breakpoint of BCR-ABL in chronic myeloid leukemia and imatinib response
不详
PHARMACOGENOMICS, 2010, 11 (09) : 1202 - 1203
[30] Fluorescence In Situ Hybridization Monitoring of BCR-ABL-Positive Neutrophils in Chronic-Phase Chronic Myeloid Leukemia Patients during the Primary Stage of Imatinib Mesylate Therapy
Naoto Takahashi
Ikuo Miura
Yoshimi Kobayashi
Masaaki Kume
Tomoko Yoshioka
Wataru Otane
Kaori Ohtsubo
Kaoru Takahashi
Atsushi Kitabayashi
Yoshinari Kawabata
Makoto Hirokawa
Hirokazu Nishijima
Ryo Ichinohasama
John DeCoteau
Akira B. Miura
Ken-ichi Sawada
International Journal of Hematology, 2005, 81 : 235 - 241

← 1 2 3 4 5 →